Research funder · Germany
European Foundation for the Study of Diabetes
Foundation
- Grants since 2016
- 353
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 1 093
- Funded works, all time
- 4 005
Grants
2022 · research · EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award
Precision treatment of type 2 diabetes: understanding biomarker predictors of differential response to oral glucose lowering therapies in the TRIMASTER crossover trial
Angus Jones · University of Exeter
2022 · research · EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe
NEUROinflammatory role of the succinate/SUCNR1 axis in obesity-related DIAbetes (NEURO_DIA)
Sonia Fernandez Veledo · Institut de Recerca Biomèdica Catalunya Sud
2022 · research · EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”
Effects of circulating extracellular vesicles on pancreatic islets during obesity
Joan-Marc Servitja · Clínic Foundation For Biomedical Research
2022 · research · EFSD/Lilly European Diabetes Research Programme
Structural bases for the fate and pathogenicity of autoreactive t-cells in type 1 diabetes
Jacinto López Sagaseta · Navarrabiomed
2022 · fellowship · EFSD/Novo Nordisk Foundation Future Leaders Award
Functional role of erythrocyte-derived non-coding RNAs in diabetes-associated vascular complications
Zhichao Zhou · Karolinska Institutet
2022 · research · EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe
Tolerogenic nanoparticles inducing regulatory B and T lymphocytes for therapy of autoimmune diabetes
Peter Van Endert · Inserm
2022 · research · EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”
Adipose-specific regulation of VEGF-B signalling in diabetic complications of liver, kidney and heart
Ulf Eriksson · Karolinska Institutet
2022 · research · EFSD/Sanofi European Diabetes Research Programme in Diabetes associated with Cardiovascular Disease
3-hydroxisobutyrate: a bridge between diabetes and atherosclerotic macrovascular disease?
Massimo Federici · University of Rome Tor Vergata
2022 · research · EFSD/Lilly European Diabetes Research Programme
Beta cell-targeting aptamer-small activating RNA-chimera in islet transplantation and regeneration
Dimitri Van Simaeys · Karolinska Institutet
2022 · fellowship · EFSD/Novo Nordisk Foundation Future Leaders Award
Adipose tissue macrophages in diabetes: regulatory mechanisms and therapeutic potential
Soren Fisker Schmidt · University of Southern Denmark
2022 · research · EFSD "New Targets for Diabetes or Obesity-related Metabolic Diseases" supported by MSD
Collagen fragments in the regulation of adipose tissue remodelling
Ingrid Wernstedt-Asterholm · University of Gothenburg
2022 · research · EFSD/Lilly European Diabetes Research Programme
A peptide-decorated anti-microbial and pro-healing hyaluronic acid dressing to promote diabetic wound healing
Shane Browne · University Of Medicine And Health Sciences
2022 · research · EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”
Glycogen dynamics in prediabetes
Mijke Buitinga · Maastricht University
2022 · research · EFSD/Lilly European Diabetes Research Programme
Identifying gene-physical activity interactions in type 2 diabetes by a reverse, targeted approach
Tuomas Kilpeläinen · University of Copenhagen
2022 · fellowship · EFSD Rising Star Fellowship Programme supported by Novo Nordisk
Identifying novel genetic causes of diabetes to give insights into mechanisms of beta cell autoimmunity
Matthew Johnson · University of Exeter
2022 · research · EFSD/Lilly European Diabetes Research Programme
Dissecting the genetic and phenotypic profile of potential subtypes of gestational diabetes and postpartum diabetes
Rashmi Prasad · Lund University
2022 · fellowship · EFSD/Lilly Young Investigator Research Award Programme
Evaluating the role of sphinganine in GLP-1 secretion: sex differences
Mark Smits · Amsterdam University Medical Centers
2022 · research · EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”
The cardio-renal-metabolic role of NLRP3 and SASP in early SGLT2i therapy in diabetics with myocardial infarction
Claire Hills · University of Lincoln
2022 · research · EFSD/Lilly EXPLORING AND APPLYING NEW STRATEGIES IN DIABETES (EXPAND) Programme
Role of exercise-induced circulating extracellular vesicles in pancreatic beta cells
Xiaofeng Zheng · Sichuan University
2022 · fellowship · EFSD/Lilly Young Investigator Research Award Programme
Exploring the role of p38α in muscle-brain communication: a novel approach for diabetes and obesity
Cintia Folgueira Cobos · Spanish National Center For Cardiovascular Research Carlos Iii
2022 · research · EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe
Separate and combined extrapancreatic effects of the incretin hormones
Filip Knop · University of Copenhagen
2022 · fellowship · EFSD/Novo Nordisk Foundation Future Leaders Award
Determinants of adipocyte lipid turnover in type 2 diabetes and cardiovascular disease
Niklas Mejhert · Karolinska Institutet
2022 · fellowship · EFSD Rising Star Fellowship Programme supported by Novo Nordisk
Perturbed glutamine turnover drives adipocyte dysfunction and insulin resistance in obesity
Salwan Maqdasy · Karolinska Institutet
2022 · research · EFSD/Lilly European Diabetes Research Programme
Discovery and characterization of a novel type of monogenic diabetes in patients with Welander distal myopathy
Åke Sjöholm · University of Gävle
2022 · research · EFSD "New Targets for Diabetes or Obesity-related Metabolic Diseases" supported by MSD
Investigating the transcriptional control of Vps37a as a new target for the treatment of type 2 diabetes
Anja Zeigerer · Helmholtz Munich, Institute For Diabetes And Cancer
2022 · research · EFSD/Lilly European Diabetes Research Programme
Elucidating the mechanisms underlying glucose regulated autophagy in pancreatic beta cells
Catherine Arden · Newcastle University
2022 · research · EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award
Proteomics in precision medicine to identify novel therapeutic targets for depressive symptoms in individuals newly diagnosed with diabetes
Haifa Maalmi · Deutsches Diabetes-Zentrum e.V.
2022 · fellowship · EFSD/Lilly Young Investigator Research Award Programme
Sodium glucose cotransporter-2 inhibitors reduce salt-sensitivity in patients with type 2 diabetes
Martina Chiriacò · University of Pisa
2022 · research · EFSD/Lilly European Diabetes Research Programme
Weak innate immune response as a risk factor for enterovirus persistence and insulin-initiated islet autoimmunity
Heikki Hyöty · Tampere University
2022 · research · EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award
Personalized Phosphoproteomics - turning phenotypic variance into scientific progress
Jørgen Wojtaszewski · University of Copenhagen
2022 · research · EFSD/Lilly European Diabetes Research Programme
The role of amylin in bone metabolism
Jonatan Bagger · University of Copenhagen
2022 · research · EFSD/Lilly European Diabetes Research Programme
Prevention of adipocyte dysfunction and metabolic disease via metabolic targeting of adipose tissue
Carolina Hagberg · Karolinska Institutet
2022 · research · EFSD/Lilly European Diabetes Research Programme
Redefining the genetic landscape of MODY
Kashyap Patel · University of Exeter
2022 · research · EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe
Fructose is central in diabetic kidney disease and mediates the protective effects of SGLT2 inhibitors
Gil Leibowitz · Hadassah Medical Center
2021 · research · EFSD Anniversary Fund Programme
Oxygen: A novel regulator of myokine production in humans
Gijs Goossens · Maastricht University Medical Centre
2021 · research · EFSD/Lilly European Diabetes Research Programme
First in human study of metabolic effects of a newly discovered polypeptide hormone
Oluf Pedersen · Copenhagen University Hospital
2021 · fellowship · EFSD Rising Star Fellowship Programme supported by Novo Nordisk
Ubiquitin-proteasome dysfunction in the pathogenesis of type 2 diabetes
Ben Stocks · University of Copenhagen
2021 · research · EFSD/Lilly European Diabetes Research Programme
Novel proteomics-based approach for the prediction of distal sensorimotor polyneuropathy
Christian Herder · German Diabetes Centre
2021 · research · EFSD Anniversary Fund Programme
Impact of moderate alcohol exposure on the development of Non-Alcoholic Steatohepatitis
Myriam Aouadi · Karolinska Institutet
2021 · research · EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe
CD200: a novel immune rheostat of pancreatic islets
Elise Dalmas · Inserm
